Discovering novel antibodies derived from the human body itself to treat neurodegenerative diseases

Project Information

HominAb

Grant agreement ID: 888016

DOI 10.3030/888016

Closed project

EC signature date 13 November 2019

Start date 1 December 2019

End date 31 May 2020

Funded under

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

MABYLON AG
Switzerland